Interventional Cardiology News and Research

RSS

Mount Sinai cardiologists use FDA-approved device for severely calcified coronary arteries

Leading interventional cardiologists at The Mount Sinai Hospital are the first in the world to use a newly U.S. Food and Drug Administration approved device for the treatment of severely calcified coronary arteries before the placement of a cardiac stent to open a blocked artery.

29 Oct 2013

Bluhm Institute enrolls first patient in SALUS trial to evaluate movable, non-metallic heart valve

Northwestern's Bluhm Cardiovascular Institute has enrolled its first participant in SALUS, a clinical trial studying the effectiveness of a prosthetic aortic heart valve that can be placed without open-heart surgery.

10 Oct 2013

CRF to present groundbreaking clinical trial findings at TCT 2013 scientific symposium

The Cardiovascular Research Foundation (CRF) has announced the late breaking trials and first report investigations that will be presented at next month's Transcatheter Cardiovascular Therapeutics (TCT) 2013 scientific symposium.

21 Sep 2013

Test evaluates benefits of fully dissolvable and temporary drug eluting stent to open heart artery blockages

The Mount Sinai Medical Center is participating in the nationwide ABSORB III clinical trial testing the performance and potential clinical benefits of a fully dissolvable and temporary drug eluting stent to open heart artery blockages.

18 Sep 2013

Loyola's success in implementing standard of care for heart attack patients recognized by AHA

Loyola University Medical Center has received the American Heart Association's Mission: Lifeline Silver Receiving Quality Achievement Award, which recognizes Loyola's commitment and success in implementing an exceptional standard of care for heart attack patients.

29 Aug 2013

AACN offers online educational support for cardiac nurses

Nurses caring for acutely or critically ill cardiovascular patients can take heart: The American Association of Critical-Care Nurses offers online educational support for cardiac nurses interested in deepening their expertise and acquiring subspecialty certification.

28 Aug 2013

Saint Luke's Heart Institute seeks talented individuals for postdoctoral cardiovascular research

Saint Luke's Mid America Heart Institute—one of the leading outcomes research centers in the nation—is seeking highly motivated, talented individuals for its two-year postdoctoral training program in cardiovascular outcomes research.

12 Aug 2013

Soligenix announces personalized medicine collaboration with SciClone

Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense countermeasures where there remains an unmet medical need, announced a personalized medicine collaboration with SciClone Pharmaceuticals in the Company's oral mucositis clinical program with SGX942.

8 Jul 2013

Saint Luke's Hospital opens Charles & Barbara Duboc Cardio Health & Wellness Center

The Charles & Barbara Duboc Cardio Health & Wellness Center is ushering in a new era for preventive cardiac care at Saint Luke's Hospital.

6 Jul 2013

Abbott starts ABSORB Japan trial to evaluate Absorb BVS in patients with CAD

Abbott today announced that it has initiated the ABSORB Japan randomized controlled clinical trial to evaluate the Absorb Bioresorbable Vascular Scaffold in patients with coronary artery disease, the most common form of heart disease.

11 Jun 2013

ArtVentive EOS Peripheral Vascular Enoluminal Occlusion system receives CE Mark certification

ArtVentive Medical Group, Inc. announced today that the Company has received its European CE Mark certification for the ArtVentive EOS Peripheral Vascular Enoluminal Occlusion system.

1 Jun 2013

Routine use of FFR at diagnostic coronary angiography changes management in 26% of patients

Routinely measuring fractional flow reserve using pressure wire assessment during coronary angiography for diagnosis of chest pain leads to significant changes in the management of one in four patients, according to results from a study reported at EuroPCR 2013.

27 May 2013

DESolve bioresorbable coronary scaffold system safe and effective, shows low rates of late lumen loss

The DESolve bioresorbable coronary scaffold system achieves good efficacy and safety with low rates of late lumen loss and major coronary adverse events at six months, show first results from the pivotal DESolve Nx trial reported at EuroPCR 2013 today.

23 May 2013

Elixir's DESolve Novolimus Eluting Bioresorbable Coronary Scaffold System receives CE Mark approval

Elixir Medical Corporation, a developer of product platforms that combine state-of-the-art medical devices with advanced pharmaceuticals, announced that it has received CE (Conformité Européenne) Mark approval for its DESolve Novolimus Eluting Bioresorbable Coronary Scaffold System.

15 May 2013

Lowering door-to-balloon times helps benefit STEMI patients, study finds

While all heart attacks have the potential to be deadly, one type is referred to as the "widow maker" because of its high risk of death. A ST segment elevation myocardial infarction is a severe type of heart attack that occurs when a blockage in a coronary artery causes heart muscle to die; without prompt treatment risk of fatality increases dramatically. Coronary angioplasty, or percutaneous coronary intervention, is the most common emergency treatment for STEMI.

30 Apr 2013

Annual scientific symposium of the Cardiovascular Research Foundation celebrates its 25th anniversary

Media registration is now open online for TCT 2013 (Transcatheter Cardiovascular Therapeutics), the annual Scientific Symposium of the Cardiovascular Research Foundation. Celebrating its 25th anniversary this year, the theme of TCT 2013 is envisioning the future, with a focus on innovation in medicine and technology.

26 Apr 2013

Loyola University Medical Center physicians deploy aortic valve through patient's abdomen

In a first-of-its-kind procedure in the United States, Loyola University Medical Center physicians have deployed an aortic valve by going through a patient's abdomen.

18 Apr 2013

Study: Patients who suffer STEMI heart attacks while hospitalized are 10 times more likely to die

If you suffer a heart attack while walking down the street and are taken to the hospital quickly, your chances of survival are very good. But if you have a heart attack while already in the hospital for something else, you are 10 times more likely to die.

18 Apr 2013

Argon Medical Devices releases OptionELITE Retrievable Vena Cava Filter

Continuing our commitment to provide best-in-class medical devices for the prevention of recurrent pulmonary embolism, Argon Medical Devices, Inc. takes another step forward with the launch of the Option™ELITE Retrievable Vena Cava Filter.

4 Apr 2013

Cedars-Sinai surgeons perform more adult heart transplants in 2012, statistics show

For the third year in a row, the Cedars-Sinai Heart Institute and Comprehensive Transplant Center performed more adult heart transplants than any other U.S. medical center, according to statistics compiled by the United Network for Organ Sharing, the nonprofit organization that manages the nation's transplant system.

21 Mar 2013